122 related articles for article (PubMed ID: 19635622)
1. Preparation and characterization of nanoparticles based on dextran-drug conjugates.
Hornig S; Bunjes H; Heinze T
J Colloid Interface Sci; 2009 Oct; 338(1):56-62. PubMed ID: 19635622
[TBL] [Abstract][Full Text] [Related]
2. Self-assembly of ibuprofen and bovine serum albumin-dextran conjugates leading to effective loading of the drug.
Li J; Yao P
Langmuir; 2009 Jun; 25(11):6385-91. PubMed ID: 19371045
[TBL] [Abstract][Full Text] [Related]
3. Xylan-based nanoparticles: prodrugs for ibuprofen release.
Daus S; Heinze T
Macromol Biosci; 2010 Feb; 10(2):211-20. PubMed ID: 19904721
[TBL] [Abstract][Full Text] [Related]
4. Nanoparticles of hydrophobically modified dextrans as potential drug carrier systems.
Aumelas A; Serrero A; Durand A; Dellacherie E; Leonard M
Colloids Surf B Biointerfaces; 2007 Sep; 59(1):74-80. PubMed ID: 17560095
[TBL] [Abstract][Full Text] [Related]
5. Development of aqueous ternary nanomatrix films: A novel 'green' strategy for the delivery of poorly soluble drugs.
Kola-Mustapha AT; Armitage D; Abioye AO
Int J Pharm; 2016 Dec; 515(1-2):616-631. PubMed ID: 27825861
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of PEG-O-chitosan nanoparticles for delivery of poor water soluble drugs: ibuprofen.
Hassani Najafabadi A; Abdouss M; Faghihi S
Mater Sci Eng C Mater Biol Appl; 2014 Aug; 41():91-9. PubMed ID: 24907742
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of methylprednisolone loaded ibuprofen modified inulin based nanoparticles and their application for drug delivery.
Zhang L; Li Y; Wang C; Li G; Zhao Y; Yang Y
Mater Sci Eng C Mater Biol Appl; 2014 Sep; 42():111-5. PubMed ID: 25063099
[TBL] [Abstract][Full Text] [Related]
8. Convenient synthesis of Ibuprofen and naproxen aminoacyl, dipeptidoyl and ester derivatives.
Katritzky AR; Jishkariani D; Narindoshvili T
Chem Biol Drug Des; 2009 Jun; 73(6):618-26. PubMed ID: 19635053
[TBL] [Abstract][Full Text] [Related]
9. Preparation, in vitro characterization and in vivo release of naproxen loaded in poly-caprolactone nanoparticles.
Rodrigues MR; Lanzarini CM; Ricci-Junior E
Pharm Dev Technol; 2011 Feb; 16(1):12-21. PubMed ID: 20001271
[TBL] [Abstract][Full Text] [Related]
10. Impact of in situ granulation and temperature quenching on crystal habit and micromeritic properties of ibuprofen-cationic dextran conjugate crystanules.
Abioye AO; Kola-Mustapha A; Ruparelia K
Int J Pharm; 2014 Feb; 462(1-2):83-102. PubMed ID: 24378327
[TBL] [Abstract][Full Text] [Related]
11. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique.
Li-Hong W; Xin C; Hui X; Li-Li Z; Jing H; Mei-Juan Z; Jie L; Yi L; Jin-Wen L; Wei Z; Gang C
Int J Pharm; 2013 Sep; 454(1):135-42. PubMed ID: 23871738
[TBL] [Abstract][Full Text] [Related]
12. Structure design of multifunctional furoate and pyroglutamate esters of dextran by polymer-analogous reactions.
Hornig S; Liebert T; Heinze T
Macromol Biosci; 2007 Mar; 7(3):297-306. PubMed ID: 17366516
[TBL] [Abstract][Full Text] [Related]
13. Real-time monitoring of the mechanism of ibuprofen-cationic dextran crystanule formation using crystallization process informatics system (CryPRINS).
Abioye AO; Chi GT; Simone E; Nagy Z
Int J Pharm; 2016 Jul; 509(1-2):264-278. PubMed ID: 27260131
[TBL] [Abstract][Full Text] [Related]
14. Solid lipid nanoparticles incorporated in dextran hydrogels: a new drug delivery system for oral formulations.
Casadei MA; Cerreto F; Cesa S; Giannuzzo M; Feeney M; Marianecci C; Paolicelli P
Int J Pharm; 2006 Nov; 325(1-2):140-6. PubMed ID: 16846705
[TBL] [Abstract][Full Text] [Related]
15. A novel ibuprofen derivative with anti-lung cancer properties: synthesis, formulation, pharmacokinetic and efficacy studies.
Cheng KW; Nie T; Ouyang N; Alston N; Wong CC; Mattheolabakis G; Papayannis I; Huang L; Rigas B
Int J Pharm; 2014 Dec; 477(1-2):236-43. PubMed ID: 25311177
[TBL] [Abstract][Full Text] [Related]
16. Influence of dextran on the bioadhesive properties of poly(anhydride) nanoparticles.
Porfire AS; Zabaleta V; Gamazo C; Leucuta SE; Irache JM
Int J Pharm; 2010 May; 390(1):37-44. PubMed ID: 19712734
[TBL] [Abstract][Full Text] [Related]
17. Facile preparation of well-defined near-monodisperse chitosan/sodium alginate polyelectrolyte complex nanoparticles (CS/SAL NPs) via ionotropic gelification: a suitable technique for drug delivery systems.
Liu P; Zhao X
Biotechnol J; 2013 Jul; 8(7):847-54. PubMed ID: 23625874
[TBL] [Abstract][Full Text] [Related]
18. Preparation and characterization of acetylated starch nanoparticles as drug carrier: Ciprofloxacin as a model.
Mahmoudi Najafi SH; Baghaie M; Ashori A
Int J Biol Macromol; 2016 Jun; 87():48-54. PubMed ID: 26893054
[TBL] [Abstract][Full Text] [Related]
19. Preparation, characterization and in vitro drug release studies of novel polymeric nanoparticles.
Nimesh S; Manchanda R; Kumar R; Saxena A; Chaudhary P; Yadav V; Mozumdar S; Chandra R
Int J Pharm; 2006 Oct; 323(1-2):146-52. PubMed ID: 16920286
[TBL] [Abstract][Full Text] [Related]
20. Formation of naproxen-polylactic acid nanoparticles from supercritical solutions and their characterization in the aerosol phase.
Gadermann M; Kular S; Al-Marzouqi AH; Signorell R
Phys Chem Chem Phys; 2009 Sep; 11(36):7861-8. PubMed ID: 19727493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
